Pancreatic Cancer Trial, Recruiting NCT05625529 Sponsor: Biological Dynamics Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT05625529
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who meet the criteria for one of the specific groups being studied in this trial (confirm with trial site)
  • People who are able to understand and agree to participate in the study
  • People who are able to provide a blood sample

Who may not be able to join:

  • People under 18 years of age
  • People who are currently pregnant
  • People who have an active cancer diagnosis other than pancreatic cancer, or who are currently receiving cancer treatment (skin cancers are an exception to this)
  • People who have previously had an organ transplant or bone marrow transplant
  • People with a history of fainting or other negative reactions when having blood drawn
  • People who have any other condition that the trial doctor believes would make participation unsuitable

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Harmeet Dhani, MD, M.Sc, Biological Dynamics

Phone: 858-202-6150

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Biological Dynamics
Registry
ClinicalTrials.gov
Start date
19 December 2022
Est. completion
1 January 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Clinical performance of ExoVerita™ assay

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov